Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: A randomised controlled trial

Annals of the Rheumatic Diseases

Volumn 71, Issue 8, 2012, Pages 1322-1328

  Laslett, Laura Louise ^a   Doré, Dawn A ^a   Quinn, Stephen J ^b   Boon, Philippa ^a   Ryan, Emma ^a   Winzenberg, Tania Maree ^a   Jones, Graeme ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE MARROW DISEASE; BONE MARROW INJURY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG INFUSION; DRUG RESPONSE; FEMALE; FLU LIKE SYNDROME; GLOMERULUS FILTRATION RATE; HEADACHE; HOSPITAL ADMISSION; HUMAN; JOINT FUNCTION; KNEE INJURY; KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; UVEITIS; VISUAL ANALOG SCALE;

ACUTE-PHASE REACTION; AGED; ARTHRALGIA; BONE DENSITY CONSERVATION AGENTS; BONE MARROW DISEASES; DIPHOSPHONATES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMIDAZOLES; INFUSIONS, INTRAVENOUS; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 84863825071     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200970     Document Type: Article

References (34)

1. Libicher M, Ivancic M, Hoffmann M, et al. Early changes in experimental osteoarthritis using the Pond-Nuki dog model: technical procedure and initial results of in vivo MR imaging. Eur Radiol 2005;15:390-4.
2. Davies-Tuck ML, Wluka AE, Wang Y, et al. The natural history of bone marrow lesions in community-based adults with no clinical knee osteoarthritis. Ann Rheum Dis 2009;68:904-8.
3. Felson DT, Chaisson CE, Hill CL, et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001;134:541-9. (Pubitemid 32245315)
4. Felson DT, Niu J, Guermazi A, et al. Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum 2007;56:2986-92. (Pubitemid 47502745)
5. Dore D, Quinn S, Ding C, et al. Natural history and clinical significance of MRI-detected bone marrow lesions at the knee: a prospective study in community dwelling older adults. Arthritis Res Ther 2010;12:R223.
6. Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003;139:330-6.
7. Davies-Tuck ML, Wluka AE, Forbes A, et al. Development of bone marrow lesions is associated with adverse effects on knee cartilage while resolution is associated with improvement-a potential target for prevention of knee osteoarthritis: a longitudinal study. Arthritis Res Ther 2010;12:R10.
8. Wluka AE, Wang Y, Davies-Tuck M, et al. Bone marrow lesions predict progression of cartilage defects and loss of cartilage volume in healthy middle-aged adults without knee pain over 2 yrs. Rheumatology (Oxford) 2008;47:1392-6.
9. Hunter DJ, Zhang Y, Niu J, et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006;54:1529-35.
10. Pelletier JP, Raynauld JP, Berthiaume MJ, et al. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study. Arthritis Res Ther 2007;9:R74.
11. Tanamas SK, Wluka AE, Pelletier JP, et al. Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study. Rheumatology (Oxford) 2010;49:2413-19.
12. Raynauld JP, Martel-Pelletier J, Haraoui B, et al.; Canadian Licofelone Study Group. Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation. Ann Rheum Dis 2011;70:1382-8.
13. Meizer R, Meraner D, Meizer E, et al. Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost. Indian J Orthop 2009;43:36-9.
14. Meizer R, Radda C, Stolz G, et al. MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr 2005;117:278-86. (Pubitemid 40767803)
15. Aigner N, Petje G, Schneider W, et al. Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-controlled study. Wien Klin Wochenschr 2005;117:130-5. (Pubitemid 40515929)
16. Wildi LM, Raynauld JP, Martel-Pelletier J, et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 2011;70:982-9.
17. Carbone LD, Nevitt MC, Wildy K, et al.; Health, Aging and Body Composition Study. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004;50:3516-25. (Pubitemid 39488676)
18. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. Ann Rheum Dis 2008;67:683-8. (Pubitemid 351571934)
19. Black DM, Delmas PD, Eastell R, et al.; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-22. (Pubitemid 46698462)
20. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
21. Altman RD, Hochberg M, Murphy WA Jr, et al. Atlas of individual radiographic features in osteoarthritis. Osteoarthr Cartil 1995;3 Suppl A:3-70.
22. Roos EM, Roos HP, Lohmander LS, et al. Knee Injury and Osteoarthritis Outcome Score (KOOS)-development of a self-administered outcome measure. J Orthop Sports Phys Ther 1998;28:88-96. (Pubitemid 28366508)
23. Bruynesteyn K, Van Der Heijde D, Boers M, et al. Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence. J Rheumatol 2002;29:2306-12. (Pubitemid 35266020)
24. Ross PD, Huang C, Karpf D, et al. Blinded reading of radiographs increases the frequency of errors in vertebral fracture detection. J Bone Miner Res 1996;11:1793-800. (Pubitemid 26367691)
25. Zhai G, Blizzard L, Srikanth V, et al. Correlates of knee pain in older adults: Tasmanian Older Adult Cohort Study. Arthritis Rheum 2006;55:264-71.
26. Langford R, McKenna F, Ratcliffe S, et al. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial. Arthritis Rheum 2006;54:1829-37. (Pubitemid 43877932)
27. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. Arthritis Rheum 2004;50:476-87. (Pubitemid 38198832)
28. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil 2010;18:476-99.
29. Kornaat PR, Kloppenburg M, Sharma R, et al. Bone marrow edema-like lesions change in volume in the majority of patients with osteoarthritis; associations with clinical features. Eur Radiol 2007;17:3073-8. (Pubitemid 350142331)
30. Roemer FW, Guermazi A, Javaid MK, et al.; MOST Study investigators. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann Rheum Dis 2009;68:1461-5.
31. Hunter DJ, Gerstenfeld L, Bishop G, et al. Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther 2009;11:R11.
32. Zanetti M, Bruder E, Romero J, et al. Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology 2000;215:835-40. (Pubitemid 30346026)
33. Reid DM, Devogelaer JP, Saag K, et al.; HORIZON investigators. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 2009;373:1253-63.
34. Reid IR, Gamble GD, Mesenbrink P, et al. Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 2010;95:4380-7.